<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Benson JA</dc:creator>
  <dc:creator>Löw K</dc:creator>
  <dc:creator>Keist R</dc:creator>
  <dc:creator>Mohler H</dc:creator>
  <dc:creator>Rudolph U</dc:creator>
  <dc:date>1998</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Amino acids in the alpha- and gamma-subunits contribute to the benzodiazepine binding site of GABA(A)-receptors. We show that the mutation of a conserved histidine residue in the N-terminal extracellular segment (alpha1H101R, alpha2H101R, alpha3H126R, and alpha5H105R) results not only in diazepam-insensitivity of the respective alphaxbeta2,3gamma2-receptors but also in an increased potentiation of the GABA-induced currents by the partial agonist bretazenil. Furthermore, Ro 15-4513, an inverse agonist at wild-type receptors, acts as an agonist at all mutant receptors. This conserved molecular switch can be exploited to identify the pharmacological significance of specific GABA(A)-receptor subtypes in vivo.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/185692</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/s0014-5793(98)00803-5</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/9714551</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>FEBS letters. - 1998</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Amino Acid Sequence</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Azides</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Base Sequence</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Benzodiazepines</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Benzodiazepinones</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Cell Line</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Diazepam</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Molecular Sequence Data</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Mutagenesis, Site-Directed</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Oligodeoxyribonucleotides</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Patch-Clamp Techniques</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Rats</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Receptors, GABA-A</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Recombinant Proteins</dc:subject>
  <dc:title xmlns:ns17="xml" ns17:lang="en">Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
